Article

Marco Ophthalmic to sell Nidek camera

Nidek has granted Marco Ophthalmic exclusive rights to sell Nidek's newest fundus camera (AFC Non-mydriatic Retinal Camera) to the optometry market.

Fremont, CA, and Jacksonville, FL-Nidek has granted Marco Ophthalmic exclusive rights to sell Nidek’s newest fundus camera (AFC Non-mydriatic Retinal Camera) to the optometry market.

Nidek is pursuing FDA clearance of the new fundus camera. Joint distribution is planned once FDA clearance is obtained. According to Nidek, this enhanced collaboration between the two companies will fundamentally increase the ability to serve customers better.

“Our customers require more efficiency and diversification in our distribution channels. The best way to meet our increasing customer demand for this product is to focus each of our corporate resources in distinct market segments, ultimately to improve customer satisfaction,” said Motoki Ozawa, Nidek president and chief executive officer.

Nidek will continue to provide sales and service to the ophthalmology market, as well as service to existing customers.

For more articles in this issue of Ophthalmology Times eReport, click here.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
© 2025 MJH Life Sciences

All rights reserved.